Lazard US Equity Value Focus (S:0P0001JE1P)
26.35
+0.56
(+2.17%)
USD |
Dec 31 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 14, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Alphabet, Inc. | 5.13% | 335.97 | 1.24% |
| Bank of America Corp. | 4.96% | 54.54 | -1.18% |
| Exxon Mobil Corp. | 3.62% | 126.54 | 2.02% |
| Marvell Technology, Inc. | 3.51% | 83.05 | 0.19% |
| Johnson & Johnson | 3.44% | 213.65 | 1.87% |
| Crown Castle, Inc. | 3.03% | 86.81 | 2.14% |
| Procter & Gamble Co. | 3.03% | 144.24 | 0.54% |
| Merck & Co., Inc. | 2.97% | 108.26 | -0.85% |
| Medtronic Plc | 2.93% | 96.42 | -0.55% |
| CVS Health Corp. | 2.92% | 80.68 | 0.40% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |